Fetal warfarin syndrome
Fetal warfarin syndrome (FWS) is a rare condition that occurs in a developing fetus when the mother takes the anticoagulant medication warfarin during pregnancy. This syndrome is characterized by a range of congenital abnormalities, primarily affecting the skeletal system, central nervous system, and facial features.
Causes[edit | edit source]
Fetal warfarin syndrome is caused by the teratogenic effects of warfarin, a vitamin K antagonist, which interferes with the normal development of the fetus. Warfarin crosses the placenta and can disrupt the synthesis of vitamin K-dependent clotting factors, leading to hemorrhages and subsequent developmental anomalies.
Symptoms[edit | edit source]
The symptoms of fetal warfarin syndrome can vary but often include:
- Nasal hypoplasia (underdeveloped nasal bridge)
- Stippled epiphyses (small, round calcifications in the cartilage of the long bones)
- Limb hypoplasia (underdeveloped limbs)
- Central nervous system abnormalities, such as microcephaly and intellectual disabilities
- Eye abnormalities, including optic atrophy and cataracts
- Congenital heart defects
Diagnosis[edit | edit source]
Diagnosis of fetal warfarin syndrome is typically based on a combination of maternal history of warfarin use during pregnancy and the presence of characteristic physical findings in the newborn. Prenatal ultrasound may detect some of the skeletal abnormalities, but a definitive diagnosis is often made postnatally.
Treatment[edit | edit source]
There is no specific treatment for fetal warfarin syndrome. Management focuses on addressing the individual symptoms and may include:
- Surgical correction of skeletal deformities
- Special education and developmental support for intellectual disabilities
- Regular monitoring and treatment of heart defects
Prevention[edit | edit source]
The primary method of preventing fetal warfarin syndrome is to avoid the use of warfarin during pregnancy. Alternative anticoagulants, such as heparin, which do not cross the placenta, are often recommended for pregnant women who require anticoagulation therapy.
Related Pages[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD